THE EFFECT OF METHOTREXATE ON THE BIOAVAILABILITY OF ORAL 6-MERCAPTOPURINE

被引：68

作者：

BALIS, FM ^{[1
]}

HOLCENBERG, JS ^{[1
]}

ZIMM, S ^{[1
]}

TUBERGEN, D ^{[1
]}

COLLINS, JM ^{[1
]}

MURPHY, RF ^{[1
]}

GILCHRIST, GS ^{[1
]}

HAMMOND, D ^{[1
]}

POPLACK, DG ^{[1
]}

机构：

[1] CHILDRENS CANC STUDY GRP,LOS ANGELES,CA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 04期

关键词：

D O I：

10.1038/clpt.1987.45

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：384 / 387

页数：4

共 6 条

[1]

FALK LC, 1976, CLIN CHEM, V22, P785

[2]

GIBALDI M, 1982, PHARMACOKINETICS

[3]

LEWIS AS, 1984, J BIOL CHEM, V259, P12

[4]

ZIMM S, 1985, CANCER RES, V45, P1869

[5] VARIABLE BIOAVAILABILITY OF ORAL MERCAPTOPURINE - IS MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA BEING OPTIMALLY DELIVERED [J].

ZIMM, S ;

COLLINS, JM ;

RICCARDI, R ;

ONEILL, D ;

NARANG, PK ;

CHABNER, B ;

POPLACK, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (17) :1005-1009

[6] INHIBITION OF 1ST-PASS METABOLISM IN CANCER-CHEMOTHERAPY - INTERACTION OF 6-MERCAPTOPURINE AND ALLOPURINOL [J].

ZIMM, S ;

COLLINS, JM ;

ONEILL, D ;

CHABNER, BA ;

POPLACK, DG .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (06) :810-817

← 1 →